Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hepatitis B, Chronic 2Carcinoma, Hepatocellular 2Recurrence 1Neoplasms 1Lymphoma, Non-Hodgkin 1Fibrosis 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 3Vincristine 2Methotrexate 2Ifosfamide 2Etoposide 2Doxorubicin 2Dexamethasone 2Cytarabine 2Vindesine 1Thiotepa 1Tenofovir 1Rituximab 1Radiotherapy 1Radiation 1Prednisolone 1Melphalan 1Lomustine 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Burkitt Lymphoma × Tenofovir × Clear all
NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Seoul National University Hospital

Phase 4 Unknown
90 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡